the gap is even wider in rural areas. 6 In our region, the differences within countries are often greater than the differences between countries.
In 2005, the World Health Organization established the Commission on Social Determinants of Health, which identified "three overarching principles to reduce health inequalities nationally and globally: improve daily living conditions; tackle the unequal distribution of power, money, and resources; and measure and understand the problem." 7 The Lancet editorial concluded "All societies must strive to close their gaps in health equity in a generation. Too much is at stake not to do so." 8 More recently, the World Federation of Public Health Associations has developed "The global charter for public health" describes the components of public health and health services and emphasizes the importance of social determinants. 9 At the 2016 APACPH Conference held at Teikyo University, the keynote address was delivered by Prof Ichiro Kawachi who emphasized the same issues in an address "Evidence from social epidemiology for the creation of a healthy future".
The need has been obvious for several decades. We have the technical tools to address most of the major causes of morbidity and mortality in region. Why can't every country have the same health parameters as Japan and Australia? All citizens need access to good nutrition, education, clean water and environment, reasonable income, developmental opportunities, access to health services and specific health promotion. Is closing the gap in a generation possible? This question has 2 clear answers. If we continue as we are, there is no chance at all. But if there is a genuine desire to change and public health and poverty alleviation are prioritized then the disparities can be overcome. A national vision is needed to create a better and fairer world where people's life chances and their health will no longer be blighted by the accident of where they happen to be born, the colour of their skin, or the lack of opportunities afforded to their parents, then the answer is: we could go a long way towards it. 7 Several recent trends in medicine threaten this vision and public health services in our region. Private pharmaceutical companies are continuously seeking greater profits. The example of the massive increases in the cost of the life-saving "Epipen" in the United States was too much even in the home of free enterprise. 10 Adverse publicity led to the company reducing costs, but it still allows for very large profits. The cost of pharmaceuticals is always a major equity issue, as the rich can afford what they need while in a country like Indonesia only 32% of the estimated active tuberculosis cases get treatment. 11 Asia has a history of successfully negotiating and bending patent requirements to make essential drugs, such as for HIV treatment, available for all. Before saying massive price rises could not happen to our region, see the article in this issue of the journal on the potential to raise pharmaceutical prices if the Trans Pacific Trade Partnership comes into force. 12 Personalized medicine has the potential to deliver gains in health and contribute to public health, but has the risk of diverting funds to individual services. 13 This may simply increase health disparities rather than improving health for all. In medicine and public health, we are constantly reminded that this is the age of the genome. Major laboratory-based projects such as the "Moon Shot" are launched to try and conquer a disease with one costly treatment. 14 In the long term (perhaps very long term), these projects may bring benefit, but in the short term, they may divert resources away from public health programs that bring immediate benefit to all and overcome health disparities. 15, 16 In the meantime, whole generations of children have increased likelihood of premature death and lose the opportunity of reaching their true potential due to deficiencies in their early nutrition and development.
APACPH and this journal want to promote more public health. We want equity in public health across our region and between the regions and socioeconomic quintiles of our countries. Give everyone an equal chance at a healthy life before we let genomics research and personalized health push public health aside. Some progress in decreasing disparities has been made, for example, in neonatal mortality in India. An analysis of demographic trends shows that 2 states of India, Kerala and Tamil Nadu, have been able to reduce disparities between socioeconomic status quintiles in low-income settings with sensible health and social policies. 17 We need to promote public health and reduce disparities all across our region.
Before we close the year, we should also mention another important publication anniversary, an important article on ethics in the New England Journal of Medicine by Henry Beecher. 18 Across the Atlantic, Maurice Pappworth was similarly collecting examples of violations of the principles of ethical medical research. 19, 20 The work of these 2 activists led to a tightening of ethical requirements in research involving humans. Of course, medical ethics did not begin in the 1960s having been discussed for centuries, and the Helsinki Declaration was already in existence following the tragedy of World War II and the Nuremburg Trials. 21 But, the work of Pappworth and Beecher ensured that ethical considerations were foremost in all medical research, a requirement that this journal continues to strictly enforce.
